drugset / Trial / NCT00245505

The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active "Drug: Crohn's Disease"

NCT00245505

Phase 3 Terminated 3 enrolled Ferring Pharmaceuticals
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to visualize the healing effect on mucosal lesions with Pentasa Sachet 4g in patients with mild to moderate active small bowel CD by video capsule endoscopy.

Timeline

Start
2009-02
Primary completion
2009-06
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Mesalamine Small molecule 2 g

Indications